We are excited to announce the launch of Neurolixis Inc.
In the current climate of pharmaceutical industry restructuring, considerable opportunities exist for  innovation in the areas of neuropsychiatry and neurology. At Neurolixis Inc. we believe that recent advances in molecular mechanisms and clinical therapies offer the possibility of improved drug treatment of serious CNS disorders. To find out more about our corporate strategy, or if you are interested in partnering with us, Contact.